Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Healthwise HoldingsHKSE:00348 -2.50% EBIT per Share is HK$0.01 as of Dec. 2025. The stock has 3 warning signs investors should review. Among 521 Healthcare Providers & Services companies, China Healthwise Holdings ranks worse than 77.16% on this metric.
China Healthwise Holdings's EBIT per Share for the
six
months ended in Dec. 2025 was HK$0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.01.
During the past 3 years, the average EBIT per Share Growth Rate was -7.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for China Healthwise Holdings's EBIT per Share or its related term are showing as below:
HKSE:00348'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -107.6 Med: -12.4 Max: 69.5
Current: -7.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of China Healthwise Holdings was 69.50% per year. The lowest was -107.60% per year. And the median was -12.40% per year.
HKSE:00348's 3-Year EBIT Growth Rate is ranked worse than 77.16% of 521
companies
in the Healthcare Providers & Services industry
Industry Median: 11.7
vs HKSE:00348: -7.30
China Healthwise Holdings (HKSE:00348) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
China Healthwise Holdings EBIT per Share Related Terms
China Healthwise Holdings EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings (HKSE:00348) has a EBIT per Share of HK$0.01 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on China Healthwise Holdings and its competitors. According to the industry distribution chart, China Healthwise Holdings ranks #402 out of 521 companies in the Healthcare Providers & Services industry, placing it in the top 77.2%.
Is China Healthwise Holdings' EBIT per Share too high?
China Healthwise Holdings' current EBIT per Share is HK$0.01. Based on the distribution chart, China Healthwise Holdings ranks #402 out of 521 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does China Healthwise Holdings' EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, China Healthwise Holdings ranks #402 out of 521 companies for EBIT per Share. This places China Healthwise Holdings in the lower half of its industry. The industry median EBIT per Share is 11.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.70, based on 521 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on China Healthwise Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Healthwise Holdings's current EBIT per Share is HK$0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Healthwise Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Healthwise Holdings (HKSE:00348) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.08 — trading 30% above its estimated fair value. The current EBIT per Share is HK$0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For China Healthwise Holdings (HKSE:00348), the current EBIT per Share is HK$0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which includes, pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00348 has been successfully added to your 
